ES2127532T3 - Preparacion de nalbufina con niveles bajos del epimero beta. - Google Patents

Preparacion de nalbufina con niveles bajos del epimero beta.

Info

Publication number
ES2127532T3
ES2127532T3 ES95920456T ES95920456T ES2127532T3 ES 2127532 T3 ES2127532 T3 ES 2127532T3 ES 95920456 T ES95920456 T ES 95920456T ES 95920456 T ES95920456 T ES 95920456T ES 2127532 T3 ES2127532 T3 ES 2127532T3
Authority
ES
Spain
Prior art keywords
nalbuphine
low levels
epimeral
beta
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920456T
Other languages
English (en)
Inventor
Frank Kavka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Chemical Inc
Original Assignee
Mallinckrodt Chemical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Chemical Inc filed Critical Mallinckrodt Chemical Inc
Application granted granted Critical
Publication of ES2127532T3 publication Critical patent/ES2127532T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA SINTESIS DE NALBUFINA. EL PROCESO DA COMO RESULTADO UN PRODUCTO QUE TIENE NIVELES MUY BAJOS DEL {BE}-EPIMERO NO DESEABLE. EL PROCESO ES UNA SINTESIS DE CINCO PASOS QUE COMIENZA CON UN COMPUESTO COMO UN N,0{SUP,3}BIS(ALCOXICARBONILO)-14-HIDROXINORMORFINONA.
ES95920456T 1994-05-31 1995-05-16 Preparacion de nalbufina con niveles bajos del epimero beta. Expired - Lifetime ES2127532T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25146094A 1994-05-31 1994-05-31

Publications (1)

Publication Number Publication Date
ES2127532T3 true ES2127532T3 (es) 1999-04-16

Family

ID=22952064

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95920456T Expired - Lifetime ES2127532T3 (es) 1994-05-31 1995-05-16 Preparacion de nalbufina con niveles bajos del epimero beta.

Country Status (11)

Country Link
US (1) US5756745A (es)
EP (1) EP0763038B1 (es)
JP (1) JP4040673B2 (es)
AT (1) ATE176472T1 (es)
AU (1) AU699114B2 (es)
CA (1) CA2191843C (es)
DE (1) DE69507697T2 (es)
ES (1) ES2127532T3 (es)
HU (1) HU224914B1 (es)
NZ (1) NZ287243A (es)
WO (1) WO1995032973A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19622866C2 (de) * 1996-06-07 1998-12-24 Viva Diagnostika Diagnostische Verwendung von Opiat-Antagonisten und -Agonisten enthaltende Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
US6114370A (en) * 1998-09-28 2000-09-05 Wall, Jr.; William H. Amnesic sedation composition and method of administering same
WO2006084389A1 (de) * 2005-02-11 2006-08-17 Cilag Ltd. Verfahren zur reinigung von noroxymorphon-verbindungen
JP2008546688A (ja) * 2005-06-16 2008-12-25 マリンクロッド・インコーポレイテッド １−ハロ−テバインまたは類似体を介する１４−ヒドロキシルオピエート類への合成経路
EP2010539B1 (en) * 2006-04-21 2017-06-14 Nektar Therapeutics Stereoselective reduction of a morphinone
DE602008004245D1 (de) * 2007-05-04 2011-02-10 Mallinckrodt Inc Verbessertes verfahren zur herstellung von 6-alpha-hydroxy-n-alkylierten opiaten
EP2167505B1 (en) * 2007-07-17 2012-11-28 Mallinckrodt LLC Preparation of n-alkylated opiates by reductive amination
WO2010017573A1 (en) * 2008-08-11 2010-02-18 Tasmanian Alkaloids Pty Limited PROCESS FOR MAKING MORPHINAN-6α-OLS
CN102227434B (zh) * 2008-09-30 2015-02-18 马林克罗特有限公司 选择性胺化酮吗啡喃的方法
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8853401B2 (en) 2009-04-24 2014-10-07 Brock University Processes for the preparation of morphinane and morphinone compounds
JP5697215B2 (ja) * 2009-06-11 2015-04-08 マリンクロッド エルエルシー 触媒的水素移動による６−α−アミノＮ−置換モルフィナンの合成
WO2010144640A2 (en) * 2009-06-11 2010-12-16 Mallinckrodt Inc. Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
GB0914338D0 (en) 2009-08-17 2009-09-30 Johnson Matthey Plc Improved process
EP2529739B1 (en) * 2010-01-29 2016-07-13 Toray Industries, Inc. Therapeutic or prophylactic agent for biliary diseases
ES2698408T3 (es) 2011-06-09 2019-02-04 SpecGx LLC Aminación reductora de 6-ceto morfinanos por transferencia de hidrógeno catalítico
AU2012304484B2 (en) 2011-09-08 2016-07-28 SpecGx LLC Production of alkaloids without the isolation of intermediates
CA2926726C (en) * 2013-11-01 2020-09-22 Mallinckrodt Llc Convenient preparation of n-substituted morphinan-6-ols from morphinan-6-ones
MX2016005187A (es) 2013-11-07 2016-08-08 Mallinckrodt Llc Produccion de 6-hidroxi morfinanos sin el aislamiento de intermediarios.
CN110330500B (zh) * 2019-07-12 2021-11-23 宜昌人福药业有限责任公司 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法
CN110305142B (zh) * 2019-07-12 2021-11-16 宜昌人福药业有限责任公司 一种6β-羟基吗啡衍生物的立体选择性合成方法
CN113845526B (zh) * 2021-01-18 2022-11-08 四川大学 一种蒂巴因衍生物及其制备方法和应用
CN112759596B (zh) * 2021-01-05 2022-03-15 宜昌人福药业有限责任公司 一种纳布啡的制备方法及其中间体
WO2023150579A2 (en) * 2022-02-01 2023-08-10 HUMANWELL PHARMACEUTICAL US, Inc. Pharmaceutical formulations containing nalbuphine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3332950A (en) * 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5112975A (en) * 1984-03-27 1992-05-12 Mallinckrodt Specialty Chemicals Company Preparation of noroxymorphone from morphine

Also Published As

Publication number Publication date
DE69507697D1 (de) 1999-03-18
HU9603289D0 (en) 1997-01-28
CA2191843C (en) 2006-05-02
EP0763038B1 (en) 1999-02-03
NZ287243A (en) 1997-12-19
AU699114B2 (en) 1998-11-19
DE69507697T2 (de) 1999-06-10
WO1995032973A1 (en) 1995-12-07
HUT77409A (hu) 1998-04-28
AU2590295A (en) 1995-12-21
JP4040673B2 (ja) 2008-01-30
CA2191843A1 (en) 1995-12-07
JPH10501223A (ja) 1998-02-03
US5756745A (en) 1998-05-26
HU224914B1 (en) 2006-04-28
EP0763038A1 (en) 1997-03-19
ATE176472T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
ES2127532T3 (es) Preparacion de nalbufina con niveles bajos del epimero beta.
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
DE69526756T2 (de) Pentapeptid-Amide und -Ester, die menslichen Krebs hemmen
MX9301787A (es) Producto nutricional liquido para alimentacion enteral.
MX9206450A (es) Proceso para la produccion de isoleucina-l.
HU901325D0 (en) Process for preparation of 4-phenyl-1,2,3,4-tetrahydro-1-naphthaleneamine derivatives
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
ES2192680T3 (es) Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
MX9602806A (es) Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales.
ES2054746T3 (es) Aditivo para piensos estabilizado y procedimiento para su preparacion.
ES2193246T3 (es) Cefalosporinas antibacterianas.
MX9207062A (es) Procedimiento para la obtencion de compuestos que presentan grupos hidroxilo, adecuadas como material de partida para el procedimiento de poliadicion de isocianato.
ES2170785T3 (es) Procedimiento para la fabricacion de arilpirroles insecticidas a traves de productos intermedios de oxazolamina.
AU8471491A (en) Oligosaccharide derivatives
ES538579A0 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
ES2174396T3 (es) Vela odorifera y su procedimiento de fabricacion.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
ES2177877T3 (es) Procedimiento para la fabricacion de 1,4-bis(aminometil)ciclohexano.
HUT58094A (en) Process for producing 20,21-dinoreburnamenin derivatives and pharmaceutical compositions comprising such compounds, as well as their intermediates
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
MX9302313A (es) Procedimiento para la obtencion de hexafluorclorobutenos.
ES2141948T3 (es) Derivados de ciclohexanona, procedimiento para su preparacion y productos intermedios del procedimiento.
MX9201219A (es) Procedimiento para la produccion de 2-cloro-1,1,1-trifluoro etano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 763038

Country of ref document: ES